Paper34175366
Nanotechnology against COVID-19: Immunization, diagnostic and therapeutic studies.
Hasanzadeh A and 8 others. J Control Release, 2021. Cited by 20 papers, by iCite.
Cite this record
ConductScience Library. Nanotechnology against COVID-19: Immunization, diagnostic and therapeutic studies. Papers, record 34175366. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34175366
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| COVID-19 | Major topic |
| Humans | |
| Immunization | |
| Nanotechnology | |
| Pandemics | |
| SARS-CoV-2 |
Source PubMed
References237
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32788923 | Stimulus-Responsive Sequential Release Systems for Drug and Gene Delivery. | Nano Today | 2020 | https://conductscience.org/library/papers/32788923 | PubMed |
| 2 | 18704954 | Vaccine adjuvants: current challenges and future approaches. | J Pharm Sci | 2009 | https://conductscience.org/library/papers/18704954 | PubMed |
| 3 | 32145190 | Liver injury in COVID-19: management and challenges. | Lancet Gastroenterol Hepatol | 2020 | https://conductscience.org/library/papers/32145190 | PubMed |
| 4 | 32313544 | Viromimetic STING Agonist-Loaded Hollow Polymeric Nanoparticles for Safe and Effective Vaccination against Middle East Respiratory Syndrome Coronavirus. | Adv Funct Mater | 2019 | https://conductscience.org/library/papers/32313544 | PubMed |
| 5 | 28782570 | Nanomedicine and advanced technologies for burns: Preventing infection and facilitating wound healing. | Adv Drug Deliv Rev | 2018 | https://conductscience.org/library/papers/28782570 | PubMed |
| 6 | 28177606 | Graphene-Based "Hot Plate" for the Capture and Destruction of the Herpes Simplex Virus Type 1. | Bioconjug Chem | 2017 | https://conductscience.org/library/papers/28177606 | PubMed |
| 7 | 32439197 | COVID-19 and Multiorgan Response. | Curr Probl Cardiol | 2020 | https://conductscience.org/library/papers/32439197 | PubMed |
| 8 | 20198909 | [Management of side effects during antiviral therapy]. | Acta Med Croatica | 2009 | https://conductscience.org/library/papers/20198909 | PubMed |
| 9 | 30474052 | Streptavidin-conjugated gold nanoclusters as ultrasensitive fluorescent sensors for early diagnosis of HIV infection. | Sci Adv | 2018 | https://conductscience.org/library/papers/30474052 | PubMed |
| 10 | 30030950 | Antiviral activity of Ribavirin nano-particles against measles virus. | Cell Mol Biol (Noisy-le-grand) | 2018 | https://conductscience.org/library/papers/30030950 | PubMed |
| 11 | 31995857 | Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. | N Engl J Med | 2020 | https://conductscience.org/library/papers/31995857 | PubMed |
| 12 | 25335768 | Development of biodegradable nanoparticles for liver-specific ribavirin delivery. | J Pharm Sci | 2014 | https://conductscience.org/library/papers/25335768 | PubMed |
| 13 | 32401715 | Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial. | Lancet | 2020 | https://conductscience.org/library/papers/32401715 | PubMed |
| 14 | 32657566 | A Surface Coating that Rapidly Inactivates SARS-CoV-2. | ACS Appl Mater Interfaces | 2020 | https://conductscience.org/library/papers/32657566 | PubMed |
| 15 | 33318701 | Arab nations first to approve Chinese COVID vaccine - despite lack of public data. | Nature | 2020 | https://conductscience.org/library/papers/33318701 | PubMed |
| 16 | 27853344 | Mitochondrial Reactive Oxygen Species and Photodynamic Therapy. | Laser Ther | 2016 | https://conductscience.org/library/papers/27853344 | PubMed |
| 17 | 33306989 | Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. | Lancet | 2021 | https://conductscience.org/library/papers/33306989 | PubMed |
| 18 | 20845061 | Efficacy and safety of intratumoral thermotherapy using magnetic iron-oxide nanoparticles combined with external beam radiotherapy on patients with recurrent glioblastoma multiforme. | J Neurooncol | 2011 | https://conductscience.org/library/papers/20845061 | PubMed |
| 19 | 22831552 | Investigation of quaternary ammonium silane-coated sand filter for the removal of bacteria and viruses from drinking water. | J Appl Microbiol | 2012 | https://conductscience.org/library/papers/22831552 | PubMed |
| 20 | 32660339 | Intranasal Antiviral Drug Delivery and Coronavirus Disease 2019 (COVID-19): A State of the Art Review. | Otolaryngol Head Neck Surg | 2020 | https://conductscience.org/library/papers/32660339 | PubMed |
Cited by11
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 20 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41359142 | Nanotechnology in COVID-19 prevention, diagnosis, and treatment: a comprehensive review. | Discov Nano | 2025 | https://conductscience.org/library/papers/41359142 | PubMed |
| 40213131 | Bioenergy-Based Closed-Loop Medical Systems for the Integration of Treatment, Monitoring, and Feedback. | Small Sci | 2023 | https://conductscience.org/library/papers/40213131 | PubMed |
| 38076059 | Hematological, inflammatory, and novel biomarkers assessment as an eminent strategy for clinical management of COVID-19. | Heliyon | 2023 | https://conductscience.org/library/papers/38076059 | PubMed |
| 37161688 | The Role of Pro-Inflammatory Mediator Interleukin-32 in Osteoclast Differentiation. | Turk J Pharm Sci | 2023 | https://conductscience.org/library/papers/37161688 | PubMed |
| 36721714 | Graphene oxide and flavonoids as potential inhibitors of the spike protein of SARS-CoV-2 variants and interaction between ligands: a parallel study of molecular docking and DFT. | Struct Chem | 2023 | https://conductscience.org/library/papers/36721714 | PubMed |
| 36507266 | Nanomaterials to combat SARS-CoV-2: Strategies to prevent, diagnose and treat COVID-19. | Front Bioeng Biotechnol | 2022 | https://conductscience.org/library/papers/36507266 | PubMed |
| 36312553 | Advances in the use of nanomaterials for nucleic acid detection in point-of-care testing devices: A review. | Front Bioeng Biotechnol | 2022 | https://conductscience.org/library/papers/36312553 | PubMed |
| 35982065 | Considering epitopes conservity in targeting SARS-CoV-2 mutations in variants: a novel immunoinformatics approach to vaccine design. | Sci Rep | 2022 | https://conductscience.org/library/papers/35982065 | PubMed |
| 35910658 | A Comprehensive Review of the Protein Subunit Vaccines Against COVID-19. | Front Microbiol | 2022 | https://conductscience.org/library/papers/35910658 | PubMed |
| 35567581 | Nasal vaccine or monoclonal therapy: Which is winning weapon against SARS-CoV-2 variants in 2022? | J Glob Health | 2022 | https://conductscience.org/library/papers/35567581 | PubMed |
| 35269270 | Anti-COVID-19 Nanomaterials: Directions to Improve Prevention, Diagnosis, and Treatment. | Nanomaterials (Basel) | 2022 | https://conductscience.org/library/papers/35269270 | PubMed |
Genes12
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/34175366
GET https://conductscience.org/api/papers/v1/34175366/references?page=2